Single-cell RNA Sequencing Analysis of Blood and Nasal Brushing From Asthma Patients Receiving a Single Dose of SAR443765, A Novel, Bispecific Anti-TSLP/Anti-IL-13 Nanobody® Molecule Reveals Significant Impact on Multiple Pathological Immune Cell Populations and Downregulation of CCL26 Expression in Epithelial Cell Subpopulations
Manisha Brahmachary(Sanofi (United States)), Virginia Savova(Harvard University), Erin Teeple(Sanofi (France)), Annemie Deiteren(Sanofi (Belgium)), S. Bafna(Sanofi (United States)), Nima Nouri(Sanofi (United States)), Emanuele de Rinaldis(Target (United States)), Benjamin T. Suratt(Sanofi (United States)), Andre H. Kurlovs(Sanofi (United States)), Heribert Staudinger(Sanofi (United States)), Gérard Sanderink(Sanofi (United States)), Annick Péleraux(Sanofi (France)), Jeffrey E. Ming(Sanofi (United States)), Davide Lucchesi(Sanofi (United Kingdom))
Cited by 0
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte
|Nature|2018|1.1k
Interplay between the human gut microbiome and host metabolism
|Nature Communications|2019|784
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|516